BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

Core Viewpoint - BioStem Technologies Inc. is set to present at the 25th Annual Needham Virtual Healthcare Conference, highlighting its focus on regenerative medicine and perinatal tissue allograft products [1][2]. Company Overview - BioStem Technologies is a publicly traded biomedical innovator specializing in the development, manufacturing, and commercialization of advanced allograft solutions derived from perinatal tissue [3]. - The company utilizes proprietary technologies such as BioRetain®, CryoTek®, and SteriTek® to optimize the preservation of natural tissue properties for clinical use [3]. - BioStem's allografts are utilized by clinicians across various specialties, indicating a broad application of its products [3]. Quality Assurance - The company's quality management system and standard operating procedures have been accredited by the American Association of Tissue Banks (AATB), ensuring compliance with current Good Tissue Practices (cGTP) and current Good Manufacturing Processes (cGMP) [4]. - BioStem's product portfolio includes well-known brands such as Neox®, Clarix®, VENDAJE®, and American Amnion™, reflecting its commitment to quality [4].